169 related articles for article (PubMed ID: 31011452)
1. Evaluation of the Graves' Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population.
Zeng P; Fan SX; Li ZJ; Peng YY; Hu YX; Xu MT; Wang M
J Ophthalmol; 2019; 2019():7602419. PubMed ID: 31011452
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients.
Villagelin D; Romaldini J; Andrade J; Santos R; Milkos A; Teixeira PFDS; Ward LS
Front Endocrinol (Lausanne); 2019; 10():192. PubMed ID: 31024443
[No Abstract] [Full Text] [Related]
3. [Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors].
Weng CY; Li ZF; Hu SD; Luo YS; Feng XT; Zhong Q; Zhang Q; Shen J
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):577-583. PubMed ID: 31365979
[No Abstract] [Full Text] [Related]
4. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves' orbitopathy.
Stoynova MA; Shinkov AD; Dimitrova ID; Yankova IA; Kovatcheva RD
Int Ophthalmol; 2024 Feb; 44(1):68. PubMed ID: 38347322
[TBL] [Abstract][Full Text] [Related]
5. Assessing Graves' ophthalmopathy-specific quality of life in Korean patients.
Choi YJ; Lim HT; Lee SJ; Lee SY; Yoon JS
Eye (Lond); 2012 Apr; 26(4):544-51. PubMed ID: 22241019
[TBL] [Abstract][Full Text] [Related]
6. Assessing the quality of life in Indian Graves' orbitopathy patients and validation of Hindi version of GO-QOL questionnaire.
Delampady K; Reddy SVB; Yadav SB
Indian J Ophthalmol; 2020 Aug; 68(8):1617-1621. PubMed ID: 32709791
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy.
Yu Y; Hu YX; Lu MX; Ouyang ZL; Xu MT; Zhao LY; Wang M
Ophthalmol Ther; 2024 Apr; 13(4):1015-1024. PubMed ID: 38376797
[TBL] [Abstract][Full Text] [Related]
8. Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy.
Lin IC; Lee CC; Liao SL
J Formos Med Assoc; 2015 Nov; 114(11):1047-54. PubMed ID: 24434244
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in a german graves orbitopathy population.
Ponto KA; Hommel G; Pitz S; Elflein H; Pfeiffer N; Kahaly GJ
Am J Ophthalmol; 2011 Sep; 152(3):483-490.e1. PubMed ID: 21676374
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Features of Graves' Orbitopathy with Elevated Intraocular Pressure.
Fan SX; Zeng P; Li ZJ; Wang J; Liang JQ; Liao YR; Hu YX; Xu MT; Wang M
J Ophthalmol; 2021; 2021():9879503. PubMed ID: 33564472
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective Trial.
Hoppe E; Lee ACH; Hoppe D; Kahaly GJ
Eur Thyroid J; 2021 Feb; 9(6):313-320. PubMed ID: 33718255
[TBL] [Abstract][Full Text] [Related]
12. GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.
Sawicka-Gutaj N; Bednarczuk T; Daroszewski J; Waligórska-Stachura J; Miśkiewicz P; Sowiński J; Bolanowski M; Ruchała M
Endokrynol Pol; 2015; 66(4):362-6. PubMed ID: 26323474
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.
Woo T; Li C; Ganesananthan S; Rajendram R; Uddin J; Lee RWJ; Dayan C; Taylor P
Thyroid; 2022 Feb; 32(2):177-187. PubMed ID: 34877883
[No Abstract] [Full Text] [Related]
14. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
[TBL] [Abstract][Full Text] [Related]
15. Measurement Properties of the Persian Translated Version of Graves Orbitopathy Quality of Life Questionnaire: A Validation Study.
Kashkouli MB; Karimi N; Aghamirsalim M; Abtahi MB; Nojomi M; Shahrad-Bejestani H; Salehi M
Ophthalmic Epidemiol; 2017 Feb; 24(1):3-10. PubMed ID: 28001456
[TBL] [Abstract][Full Text] [Related]
16. Quality of life improves after strabismus surgery in patients with Graves' orbitopathy.
Jellema HM; Merckel-Timmer E; Kloos R; Saeed P; Mourits MP
Eur J Endocrinol; 2014 May; 170(5):785-9. PubMed ID: 24493116
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
Son BJ; Lee SY; Yoon JS
Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
[TBL] [Abstract][Full Text] [Related]
18. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
[TBL] [Abstract][Full Text] [Related]
20. Facial expression of patients with Graves' orbitopathy.
Lei C; Qu M; Sun H; Huang J; Huang J; Song X; Zhai G; Zhou H
J Endocrinol Invest; 2023 Oct; 46(10):2055-2066. PubMed ID: 37005981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
